Lisata Therapeutics, Inc. (LSTA) stock
LSTANasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.91−0.07 (-7.15%)
Close on Nov 19, 2026Market cap $8.20MP/E –Yield –
Lisata Therapeutics gross profit
Gross profit is revenue minus the direct cost of the goods and services sold.
Lisata Therapeutics's gross profit for the twelve months ending Mar 31, 2017 was $2.77M. For fiscal 2016 it was $4.15M, up 78.1% from the year before. The highest annual figure on record is $20.15M in fiscal 2010.
Annual gross profit
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2016 | Dec 31, 2016 | $4.15M | +78.1% |
| FY2015 | Dec 31, 2015 | $2.33M | +3.0% |
| FY2014 | Dec 31, 2014 | $2.26M | +31.3% |
| FY2013 | Dec 31, 2013 | $1.72M | -27.7% |
| FY2012 | Dec 31, 2012 | $2.38M | +69.6% |
| FY2011 | Dec 31, 2011 | $1.40M | -93.0% |
| FY2010 | Dec 31, 2010 | $20.15M | – |
Quarterly gross profit
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2017 | Mar 31, 2017 | -$119.60K | – |
| Q4 FY2016 | Dec 31, 2016 | $931.36K | – |
| Q3 FY2016 | Sep 30, 2016 | $706.27K | – |
See a number that looks wrong?